KISQALI 200 mg/1
ribociclib · TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
KISQALI is a tablet, film coated containing ribociclib at 200 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- KISQALI
- Generic Name
- ribociclib
- NDC Code (Product)
0078-0874- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209092
- Marketing Start
- 03/13/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is KISQALI used for?
KISQALI contains ribociclib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is KISQALI a controlled substance?
KISQALI is not classified as a controlled substance by the DEA.
What is the generic name for KISQALI?
The generic name for KISQALI is ribociclib. There are no other listed brand versions of ribociclib.
What is the NDC code for KISQALI 200 mg/1?
The NDC (National Drug Code) for KISQALI 200 mg/1 is 0078-0874, listed by Novartis Pharmaceuticals Corporation.
Other KISQALI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)